Trending...
- Everwild Music Festival Unveils 2026 Schedule: No Overlapping Sets, Longer Performances, and Epic Late-Night Sets!
- MAG Magna Corp Targets Trillion-Dollar Opportunity by Tokenizing Rare Earth Assets Critical to AI, EVs, & Defense: MAG Magna Corp.: Stock Symbol: MGNC
- Special Alert! Highly Undervalued Stock: $317M Revenue in 2025 for Telecom Leader IQSTEL, Inc. (N A S D A Q: IQST)
TAMPA, Fla. - ncarol.com -- Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization's 2024 Drug Shortage Guardian Award to Fresenius Kabi USA, a health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition.
Fresenius Kabi USA received the award in recognition of its exceptional teamwork and patient focus during the critical chemotherapy shortages of 2023. The patient-centric focus and culture of Fresenius Kabi enabled the company to rapidly increase output and urgently steward emergency supply to thousands of customers and patients in need of critical therapies.
The Drug Shortage Guardian Award is presented annually to an organization and its people for exhibiting exceptional patient-centered work during a drug shortage crisis. Angels for Change defines a guardian as a "defender; one who guards, protects those in need."
"It is important to recognize individuals within the supply chain for extraordinary, patient-focused work. In highlighting gold-standard work we foster change and support building the resilient supply chain of the future. We are proud to present our 2024 Guardian Award to Fresenius Kabi and its amazing employees who tirelessly strive to ensure patient access to lifesaving medicines across the country, even in dire shortage situations," said Founder and Chief Change Maker of Angels for Change, Laura Bray.
More on ncarol.com
In addition to recognizing Fresenius Kabi USA, Angels for Change also presented individual Drug Shortage Guardian Awards to two Fresenius employees: Karen Twardzik, Vice President, Customer Service Operations, and Danielle Gross, Manager, Customer Service.
These guardians' extraordinary work and leadership exceeded their normal tasks to navigate within the supply chain to ensure life-saving medicines were delivered to customers and patients experiencing dire shortages. Their heroic efforts helped save lives across the nation.
"At Fresenius Kabi, we exist to put lifesaving medicines and technologies in the hands of people who care for patients. We are honored to receive this recognition from Angels for Change and look forward to supporting the important work of Laura and the mission of Angels for Change. We will continue to do our part to put an end to essential medicine (or drug) shortages," said John Ducker, president and CEO, Fresenius Kabi, Region U.S.
The awards were presented at Fresenius Kabi's U.S. headquarters in Lake Zurich, Ill. on May 16th, 2024. Fresenius Kabi USA leadership and employees joined Angels for Change founder Laura Bray during the award presentation. Following this meeting another presentation occurred at nearby Melrose Park, Ill. where Fresenius Kabi operates a state-of-the art sterile injectable manufacturing site. Here, Bray presented a guardian award to Fresenius Kabi frontline workers who have worked tirelessly to increase supply of needed medicines for patients.
More on ncarol.com
About Angels for Change
Angels for Change is a volunteer-supported, global, 501c3 organization started in Tampa, Fla. that is on a mission to end drug shortages through advocacy, awareness, and a resilient supply chain. Founder, Laura Bray, was driven to start Angels for Change after her own child faced three life-saving drug shortages in nine months of pediatric cancer treatment. Each day Angels for Change advocates on behalf of any patient in a life-saving drug shortage, while building relationships with patients and members of the pharmaceutical supply chain to end all healthcare crises created by drug shortages.
www.angelsforchange.org
About Fresenius Kabi USA
Fresenius Kabi, an operating company of Fresenius, is a global healthcare organization that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used for the therapy and care of patients with critical and chronic conditions. The company is actively involved in efforts to end drug shortages, has invested nearly a billion dollars in U.S. pharmaceutical manufacturing and distribution, and is a past recipient of a Drug Shortage Assistance Award from the U.S. Food and Drug Administration. www.fresenius-kabi.com/us/
Fresenius Kabi USA received the award in recognition of its exceptional teamwork and patient focus during the critical chemotherapy shortages of 2023. The patient-centric focus and culture of Fresenius Kabi enabled the company to rapidly increase output and urgently steward emergency supply to thousands of customers and patients in need of critical therapies.
The Drug Shortage Guardian Award is presented annually to an organization and its people for exhibiting exceptional patient-centered work during a drug shortage crisis. Angels for Change defines a guardian as a "defender; one who guards, protects those in need."
"It is important to recognize individuals within the supply chain for extraordinary, patient-focused work. In highlighting gold-standard work we foster change and support building the resilient supply chain of the future. We are proud to present our 2024 Guardian Award to Fresenius Kabi and its amazing employees who tirelessly strive to ensure patient access to lifesaving medicines across the country, even in dire shortage situations," said Founder and Chief Change Maker of Angels for Change, Laura Bray.
More on ncarol.com
- YOKE Expands NIL Club Into Athlete-Led Commerce With Athlete Merch Launch
- Floor Kings Announces Official Launch of Premier Epoxy Flooring Services Across Arizona
- STEM For Kids and Operation Xcel Partner to Drive Student Success Through Innovative STEM Pilot
- UK Buyers Purchase Luxury Home in Keene's Pointe, Windermere (Orlando, Florida)
- Instant IP Launches Rapid Takedown Service to Combat IP Theft, Deepfakes, and Copycat Websites
In addition to recognizing Fresenius Kabi USA, Angels for Change also presented individual Drug Shortage Guardian Awards to two Fresenius employees: Karen Twardzik, Vice President, Customer Service Operations, and Danielle Gross, Manager, Customer Service.
These guardians' extraordinary work and leadership exceeded their normal tasks to navigate within the supply chain to ensure life-saving medicines were delivered to customers and patients experiencing dire shortages. Their heroic efforts helped save lives across the nation.
"At Fresenius Kabi, we exist to put lifesaving medicines and technologies in the hands of people who care for patients. We are honored to receive this recognition from Angels for Change and look forward to supporting the important work of Laura and the mission of Angels for Change. We will continue to do our part to put an end to essential medicine (or drug) shortages," said John Ducker, president and CEO, Fresenius Kabi, Region U.S.
The awards were presented at Fresenius Kabi's U.S. headquarters in Lake Zurich, Ill. on May 16th, 2024. Fresenius Kabi USA leadership and employees joined Angels for Change founder Laura Bray during the award presentation. Following this meeting another presentation occurred at nearby Melrose Park, Ill. where Fresenius Kabi operates a state-of-the art sterile injectable manufacturing site. Here, Bray presented a guardian award to Fresenius Kabi frontline workers who have worked tirelessly to increase supply of needed medicines for patients.
More on ncarol.com
- Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
- Permian Museum Adds Photos of Fossils Discovered on a Meteorite
- This Saturday: Open House for Manalapan's Newest Single Family Home Community
- Radarsign™ Awarded Sourcewell Contract Expanding Access to Traffic Safety Solutions
- MainConcept and NETINT Bring VPU Acceleration to Easy Video API
About Angels for Change
Angels for Change is a volunteer-supported, global, 501c3 organization started in Tampa, Fla. that is on a mission to end drug shortages through advocacy, awareness, and a resilient supply chain. Founder, Laura Bray, was driven to start Angels for Change after her own child faced three life-saving drug shortages in nine months of pediatric cancer treatment. Each day Angels for Change advocates on behalf of any patient in a life-saving drug shortage, while building relationships with patients and members of the pharmaceutical supply chain to end all healthcare crises created by drug shortages.
www.angelsforchange.org
About Fresenius Kabi USA
Fresenius Kabi, an operating company of Fresenius, is a global healthcare organization that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used for the therapy and care of patients with critical and chronic conditions. The company is actively involved in efforts to end drug shortages, has invested nearly a billion dollars in U.S. pharmaceutical manufacturing and distribution, and is a past recipient of a Drug Shortage Assistance Award from the U.S. Food and Drug Administration. www.fresenius-kabi.com/us/
Source: AngelsForChange.org
0 Comments
Latest on ncarol.com
- Expert Law Attorneys' Top Law Firms to Know: March 2026
- Transform Your Home with G&R Landmark Renovations
- Green Office Partner Strengthens Global Operations with Mexico-Based DigitalVAAR Partnership
- P-Wave Classics Announces the Publication of The Female Quixote, Volume I, by Charlotte Lennox
- Everwild Music Festival Unveils 2026 Schedule: No Overlapping Sets, Longer Performances, and Epic Late-Night Sets!
- Riggo Production Studio Launches Monthly Content Package for Growing Brands
- Accelerating into Active Oil Production with over 100 Barrels per day now being produced as Dual-revenue engine begins Generating Cash Flow: $IBG
- Finland emerges as clear Eurovision 2026 favourite – analysis of 12 bookmakers by Vedonlyöntisivut
- Mac Mountain Selects netElastic vRouter for LightCraft Broadband-as-a-Service Platform
- 88% Revenue Growth; Charging Into the Future with Explosive Growth, Strategic EV Expansion and Infrastructure Dominance Signal a Breakout Opportunity
- Forge Resources Unlocks Major Gold-Copper System in Yukon as Drilling Success and Strategic Assets Fuel High-Impact Growth Story for: $FRGGF
- Game Day Private Jets Launches REVUP Platform to Transform Fan & Donor Travel Into a Revenue Engine for College Athletics
- Heritage at South Brunswick Team Celebrates Major Wins at NJBA Sales and Marketing Awards
- InterMountain Announces the Opening of TownePlace Suites Reno
- Home Builders Association of Durham, Orange & Chatham Counties Awards Local Scholarships
- New from Regal House Publishing, A Woman in Pink, devotion to an addict is a love story gone wrong
- MAG Magna Corp Targets Trillion-Dollar Opportunity by Tokenizing Rare Earth Assets Critical to AI, EVs, & Defense: MAG Magna Corp.: Stock Symbol: MGNC
- SnapTax Launches AI-Powered Tax Planning Platform for Freelancers and 1099 Workers — Now Free for 90 Days
- Congressional Roundtable Exposes Mental Health Crisis: More Spending and Treatment, Worse Results – CCHR Demands Accountability
- Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking